26
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer.

      The New England journal of medicine
      Massachusetts Medical Society

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Bevacizumab, a monoclonal antibody against vascular endothelial growth factor, has been shown to benefit patients with a variety of cancers.

          Related collections

          Author and article information

          Journal
          17167137
          10.1056/NEJMoa061884

          Comments

          Comment on this article

          scite_